Active principles | Rating | Bibliogr. | Expand | |
---|---|---|---|---|
1 | HLA-B27 Antigen | 100 | + | |
2 | Receptors, Tumor Necrosis Factor | 72 | + | |
3 | Tumor Necrosis Factor-alpha | 56 | + | |
4 | Immunoglobulin G | 44 | + | |
5 | Antibodies, Monoclonal | 43 | + | |
6 | Sulfasalazine | 41 | + | |
7 | C-Reactive Protein | 22 | + | |
8 | Antibodies, Monoclonal, Humanized | 19 | + | |
9 | Phenylbutazone | 18 | + | |
10 | Naproxen | 18 | + | |
11 | Matrix Metalloproteinase 3 | 17 | + | |
12 | Apazone | 13 | + | |
13 | Biological Products | 11 | + | |
14 | Radium | 11 | + | |
15 | Wnt3A Protein | 10 | + | |
16 | Methotrexate | 9 | + | |
17 | Homogentisic Acid | 9 | + | |
18 | Thorium | 8 | + | |
19 | Secretory Component | 8 | + | |
20 | Piroxicam | 8 | + | |
21 | Samarium | 7 | + | |
22 | Intercellular Signaling Peptides and Proteins | 7 | + | |
23 | Osteoprotegerin | 7 | + | |
24 | Ataxia Telangiectasia Mutated Proteins | 7 | + | |
25 | Acute-Phase Proteins | 6 | + | |
26 | Recombinant Fusion Proteins | 5 | + | |
27 | Diclofenac | 5 | + | |
28 | Thalidomide | 5 | + | |
29 | Diphosphonates | 4 | + | |
30 | Isoxazoles | 4 | + | |
31 | Immunoglobulin A | 4 | + | |
32 | Sulfones | 4 | + | |
33 | RANK Ligand | 4 | + | |
34 | Interleukin-6 | 4 | + | |
35 | Pyridines | 3 | + | |
36 | Cytokines | 2 | + |